T Cell News and Research

Latest T Cell News and Research

Researchers discover new mechanism to burn body fat

Researchers reporting in the February 3rd issue of Cell Metabolism may have a new way to trick the body into consuming more energy. The target in this case is an enzyme that indirectly controls the activity of what the researchers refer to as the "energy master switch." It boils down to this:

2 Feb 2010

Research offers new hope for rare metabolic disorder

A research team led by biochemist Scott Garman at the University of Massachusetts Amherst has for the first time determined the mechanism of one of the cell's "recycling" enzymes, human alpha-galactosidase or alpha-GAL, as it breaks down substances in the lysosome, the cell's recycling center.

2 Feb 2010

Gentag signs license agreement to develop and commercialize post surgery wireless skin patch

Gentag, Inc. and The CORE Institute® are pleased to announce the signing of a license agreement to develop and commercialize a disposable wireless skin patch to allow patients to self monitor themselves in the comfort of their homes after orthopedic surgery in hospitals through the use of cell phones

2 Feb 2010

New formulated soy product offers heart health benefits

Just in time for Heart Health Month, EcoNugenics introduces the newest in their scientifically formulated product line: CIRCUTOL™ Cardiovascular Health Support.

2 Feb 2010

Cytheris broadens patent protection for recombinant human interleukin-7

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO’s official communication that the Company’s application has successfully completed examination and that a patent will be issued.

2 Feb 2010

Spectrum Pharmaceuticals signs co-development and commercialization agreement with TopoTarget A/S

Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has entered into a co-development and commercialization agreement with TopoTarget A/S for Belinostat, a novel histone deacetylase (HDAC) inhibitor.

2 Feb 2010

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on ALL

Treating acute lymphocytic leukemia (ALL) can bring many challenges, particularly in the adult population. To optimally manage this disease in adult patients, healthcare professionals must understand and identify characteristics of high-risk disease, utilize best strategies for preventing central nervous system relapse, and recognize the important role of post-remission hematopoietic stem cell transplantation in ALL therapy.

2 Feb 2010

Winner of ABC Best Paper Award 2009

The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.

2 Feb 2010

Researchers identify a key piece in the ageing process

Understanding how aged and damaged mother cells manage to form new and undamaged daughter cells is one of the toughest riddles of ageing, but scientists now know how yeast cells do it. In a groundbreaking study researchers from the University of Gothenburg, Sweden, show how the daughter cell uses a mechanical "conveyor belt" to dump damaged proteins in the mother cell.

2 Feb 2010

Minimally invasive living donor liver retrieval for pediatric transplant

NewYork-Presbyterian Morgan Stanley Children's Hospital is the only medical center in the United States to offer minimally invasive liver donation for pediatric transplantation. Surgeons use a laparoscopic technique to remove a section of liver from a living donor for implantation in a pediatric patient -- typically a parent donating to their child. The innovative approach promises dramatically improved recovery for the donor.

2 Feb 2010

BRAIN, Bayer Schering Pharma collaborate in production process optimisation of steroid compounds

BRAIN AG, an European leader in white biotechnology and the global top 10 pharmaceutical corporation Bayer Schering Pharma AG co-operate in the field of production process optimisation of steroid compounds. The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds using optimised microbial production strains taking plant derived raw materials as starting material.

2 Feb 2010

Scientists and engineers conduct research on environmental health impacts of nanomaterials

As researchers around the world hasten to employ nanotechnology to improve production methods for applications that range from manufacturing materials to creating new pharmaceutical drugs, a separate but equally compelling challenge exists.

2 Feb 2010

Elbit Imaging intends to restructure its bio-tech and medical holdings under a subsidiary

Elbit Imaging ("Elbit Imaging" "Company") announced today that it intends to restructure its bio-tech and medical holdings (InSightec - 60%, and Gamida Cell - 28%; both on a fully diluted basis) under a wholly-owned Elbit Imaging subsidiary and to offer shares of such subsidiary in a public offering on the Tel Aviv Stock Exchange ("IPO").

2 Feb 2010

First annual Translational Regenerative Medicine Forum to be held in Winston-Salem

The Regenerative Medicine Foundation today announced the first annual Translational Regenerative Medicine Forum to be held April 6-8, 2010 at the Benton Convention Center in Winston-Salem.

2 Feb 2010

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

Dr Jorg Hartkamp and Dr Stefan Roberts have found that the protease HtrA2 can "clean" cells of the oncogene WT1, which is found at high levels in many leukaemias and solid cancers such as breast and lung cancer.

From The University of Manchester 2 Feb 2010

Pandemic H1N1 influenza of swine origin has distinct means of transmission from seasonal flu

Current research suggests that pandemic H1N1 influenza of swine origin has distinct means of transmission from the seasonal flu, yet does not result in the pathogenic severity of avian flu viruses.

2 Feb 2010

Unusual molecule in brain and retina can trigger vision loss

Scientists have identified a double agent in the eye that, once triggered, can morph from neuron protector to neuron killer. The discovery has significant health implications since the neurons killed through this process results in vision loss and blindness.

2 Feb 2010

Decreased release of neurotransmitter acetylcholine contributes to heart failure

Scientists at the Robarts Research Institute at The University of Western Ontario, working in collaboration with researchers in Brazil, have used a unique genetically-modified mouse line to reveal a previously unidentified mechanism contributing to heart failure.

2 Feb 2010

Study evaluates hepatocyte transplantation as an alternative to liver transplantation

A research team from the National Taiwan University Hospital has evaluated the efficiency of transplanted hepatocyte (liver) cells in animal models severely damaged by two kinds of chemical toxicity to see whether and how transplanted hepatocytes were able to efficiently repopulate the toxin-induced, severely damaged livers.

2 Feb 2010

Studies suggest potential therapeutic targets for food poisoning, TB and autoimmune diseases

Researchers at National Jewish Health have discovered how the virulent food-borne bacteria Listeria monocytogenes induces infected immune cells to sabotage their own defensive response.

2 Feb 2010

T Cell News and Research

Latest T Cell News and Research

Researchers discover new mechanism to burn body fat

Research offers new hope for rare metabolic disorder

Gentag signs license agreement to develop and commercialize post surgery wireless skin patch

New formulated soy product offers heart health benefits

Cytheris broadens patent protection for recombinant human interleukin-7

Spectrum Pharmaceuticals signs co-development and commercialization agreement with TopoTarget A/S

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on ALL

Winner of ABC Best Paper Award 2009

Researchers identify a key piece in the ageing process

Minimally invasive living donor liver retrieval for pediatric transplant

BRAIN, Bayer Schering Pharma collaborate in production process optimisation of steroid compounds

Scientists and engineers conduct research on environmental health impacts of nanomaterials

Elbit Imaging intends to restructure its bio-tech and medical holdings under a subsidiary

First annual Translational Regenerative Medicine Forum to be held in Winston-Salem

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

Pandemic H1N1 influenza of swine origin has distinct means of transmission from seasonal flu

Unusual molecule in brain and retina can trigger vision loss

Decreased release of neurotransmitter acetylcholine contributes to heart failure

Study evaluates hepatocyte transplantation as an alternative to liver transplantation

Studies suggest potential therapeutic targets for food poisoning, TB and autoimmune diseases

Immunology eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in